| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | high voltage-gated calcium channel activity | 1.59e-05 | 14 | 72 | 3 | GO:0008331 | |
| GeneOntologyMolecularFunction | structural constituent of skin epidermis | 1.72e-05 | 43 | 72 | 4 | GO:0030280 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of cytosolic calcium levels | 4.54e-04 | 9 | 72 | 2 | GO:0099511 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity involved in regulation of presynaptic cytosolic calcium levels | 4.54e-04 | 9 | 72 | 2 | GO:0099626 | |
| GeneOntologyMolecularFunction | voltage-gated calcium channel activity | 6.11e-04 | 46 | 72 | 3 | GO:0005245 | |
| GeneOntologyMolecularFunction | antigen binding | 6.18e-04 | 190 | 72 | 5 | GO:0003823 | |
| GeneOntologyMolecularFunction | calcium channel activity | 1.22e-03 | 129 | 72 | 4 | GO:0005262 | |
| GeneOntologyBiologicalProcess | intermediate filament cytoskeleton organization | 1.56e-09 | 99 | 70 | 8 | GO:0045104 | |
| GeneOntologyBiologicalProcess | intermediate filament-based process | 1.69e-09 | 100 | 70 | 8 | GO:0045103 | |
| GeneOntologyBiologicalProcess | intermediate filament organization | 6.30e-09 | 75 | 70 | 7 | GO:0045109 | |
| GeneOntologyBiologicalProcess | keratinization | 1.16e-05 | 87 | 70 | 5 | GO:0031424 | |
| GeneOntologyCellularComponent | intermediate filament cytoskeleton | 2.81e-05 | 263 | 70 | 7 | GO:0045111 | |
| GeneOntologyCellularComponent | cornified envelope | 8.46e-05 | 69 | 70 | 4 | GO:0001533 | |
| GeneOntologyCellularComponent | keratohyalin granule | 1.10e-04 | 5 | 70 | 2 | GO:0036457 | |
| GeneOntologyCellularComponent | intermediate filament | 1.13e-04 | 227 | 70 | 6 | GO:0005882 | |
| GeneOntologyCellularComponent | immunoglobulin complex | 2.37e-04 | 166 | 70 | 5 | GO:0019814 | |
| GeneOntologyCellularComponent | keratin filament | 3.16e-04 | 97 | 70 | 4 | GO:0045095 | |
| GeneOntologyCellularComponent | voltage-gated calcium channel complex | 4.92e-04 | 46 | 70 | 3 | GO:0005891 | |
| GeneOntologyCellularComponent | cell tip | 1.46e-03 | 17 | 70 | 2 | GO:0051286 | |
| GeneOntologyCellularComponent | supramolecular fiber | THSD4 CACNA1C DES KRT6A KRT6B MYO1A KRT6C KRT77 DNAJB6 PKP2 CCT7 | 1.77e-03 | 1179 | 70 | 11 | GO:0099512 |
| GeneOntologyCellularComponent | supramolecular polymer | THSD4 CACNA1C DES KRT6A KRT6B MYO1A KRT6C KRT77 DNAJB6 PKP2 CCT7 | 1.87e-03 | 1187 | 70 | 11 | GO:0099081 |
| GeneOntologyCellularComponent | calcium channel complex | 1.89e-03 | 73 | 70 | 3 | GO:0034704 | |
| GeneOntologyCellularComponent | dendritic shaft | 1.97e-03 | 74 | 70 | 3 | GO:0043198 | |
| GeneOntologyCellularComponent | cell pole | 2.02e-03 | 20 | 70 | 2 | GO:0060187 | |
| HumanPheno | Steatocystoma multiplex | 9.67e-05 | 4 | 21 | 2 | HP:0012035 | |
| HumanPheno | Eruptive vellus hair cyst | 9.67e-05 | 4 | 21 | 2 | HP:0025248 | |
| HumanPheno | Linear arrays of macular hyperkeratoses in flexural areas | 1.61e-04 | 5 | 21 | 2 | HP:0007490 | |
| HumanPheno | Hyperplastic callus formation | 1.61e-04 | 5 | 21 | 2 | HP:0030268 | |
| HumanPheno | White lesion of the oral mucosa | 1.85e-04 | 28 | 21 | 3 | HP:0025125 | |
| HumanPheno | Oral leukoplakia | 1.85e-04 | 28 | 21 | 3 | HP:0002745 | |
| Domain | VDCC_a1su_IQ | 1.60e-06 | 7 | 68 | 3 | IPR014873 | |
| Domain | GPHH | 1.60e-06 | 7 | 68 | 3 | PF16905 | |
| Domain | GPHH_dom | 1.60e-06 | 7 | 68 | 3 | IPR031649 | |
| Domain | Ca_chan_IQ | 1.60e-06 | 7 | 68 | 3 | SM01062 | |
| Domain | Ca_chan_IQ | 1.60e-06 | 7 | 68 | 3 | PF08763 | |
| Domain | Keratin_2_head | 1.62e-06 | 24 | 68 | 4 | IPR032444 | |
| Domain | Keratin_2_head | 1.62e-06 | 24 | 68 | 4 | PF16208 | |
| Domain | Keratin_II | 2.26e-06 | 26 | 68 | 4 | IPR003054 | |
| Domain | Intermediate_filament_CS | 3.29e-06 | 63 | 68 | 5 | IPR018039 | |
| Domain | VDCCAlpha1 | 5.44e-06 | 10 | 68 | 3 | IPR002077 | |
| Domain | Filament | 5.96e-06 | 71 | 68 | 5 | SM01391 | |
| Domain | IF | 6.38e-06 | 72 | 68 | 5 | PS00226 | |
| Domain | Filament | 6.83e-06 | 73 | 68 | 5 | PF00038 | |
| Domain | IF | 8.33e-06 | 76 | 68 | 5 | IPR001664 | |
| Domain | KH_1 | 3.55e-04 | 38 | 68 | 3 | PF00013 | |
| Domain | - | 3.84e-04 | 39 | 68 | 3 | 3.30.1370.10 | |
| Domain | KH | 4.14e-04 | 40 | 68 | 3 | SM00322 | |
| Domain | KH_dom | 4.14e-04 | 40 | 68 | 3 | IPR004087 | |
| Domain | KH_TYPE_1 | 4.79e-04 | 42 | 68 | 3 | PS50084 | |
| Domain | KH_dom_type_1 | 5.49e-04 | 44 | 68 | 3 | IPR004088 | |
| Domain | PLAC | 1.16e-03 | 14 | 68 | 2 | PF08686 | |
| Domain | Channel_four-helix_dom | 1.17e-03 | 57 | 68 | 3 | IPR027359 | |
| Domain | - | 1.17e-03 | 57 | 68 | 3 | 1.20.120.350 | |
| Domain | PLAC | 2.15e-03 | 19 | 68 | 2 | PS50900 | |
| Domain | PLAC | 2.15e-03 | 19 | 68 | 2 | IPR010909 | |
| Domain | S100_CABP | 4.32e-03 | 27 | 68 | 2 | PS00303 | |
| Domain | S_100 | 4.32e-03 | 27 | 68 | 2 | PF01023 | |
| Domain | S100_Ca-bd_sub | 4.64e-03 | 28 | 68 | 2 | IPR013787 | |
| Domain | S100/CaBP-9k_CS | 4.64e-03 | 28 | 68 | 2 | IPR001751 | |
| Domain | S_100 | 4.64e-03 | 28 | 68 | 2 | SM01394 | |
| Domain | GPS | 6.80e-03 | 34 | 68 | 2 | SM00303 | |
| Domain | RRM_1 | 6.98e-03 | 208 | 68 | 4 | PF00076 | |
| Domain | GPS | 8.01e-03 | 37 | 68 | 2 | IPR000203 | |
| Domain | RRM | 8.08e-03 | 217 | 68 | 4 | SM00360 | |
| Domain | Ion_trans_dom | 8.32e-03 | 114 | 68 | 3 | IPR005821 | |
| Domain | Ion_trans | 8.32e-03 | 114 | 68 | 3 | PF00520 | |
| Domain | RRM_dom | 9.43e-03 | 227 | 68 | 4 | IPR000504 | |
| Domain | RRM | 9.87e-03 | 230 | 68 | 4 | PS50102 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_CAM_VGCC_RYR_SIGNALING_PATHWAY | 6.00e-06 | 11 | 48 | 3 | M47958 | |
| Pathway | KEGG_MEDICUS_REFERENCE_VGCC_CA2_APOPTOTIC_PATHWAY | 6.25e-05 | 23 | 48 | 3 | M47666 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 7.42e-05 | 129 | 48 | 5 | M27649 | |
| Pathway | KEGG_MEDICUS_REFERENCE_CA2_ENTRY_VOLTAGE_GATED_CA2_CHANNEL | 8.08e-05 | 25 | 48 | 3 | M47948 | |
| Pathway | KEGG_MEDICUS_VARIANT_SCRAPIE_CONFORMATION_PRPSC_TO_VGCC_CA2_APOPTOTIC_PATHWAY | 1.69e-04 | 6 | 48 | 2 | M47762 | |
| Pathway | REACTOME_FORMATION_OF_THE_CORNIFIED_ENVELOPE | 2.14e-04 | 87 | 48 | 4 | MM15351 | |
| Pathway | REACTOME_CD22_MEDIATED_BCR_REGULATION | 2.25e-04 | 35 | 48 | 3 | MM17219 | |
| Pathway | REACTOME_CLASSICAL_ANTIBODY_MEDIATED_COMPLEMENT_ACTIVATION | 3.11e-04 | 39 | 48 | 3 | MM17212 | |
| Pathway | REACTOME_ROLE_OF_LAT2_NTAL_LAB_ON_CALCIUM_MOBILIZATION | 4.76e-04 | 45 | 48 | 3 | MM14912 | |
| Pathway | KEGG_TYPE_II_DIABETES_MELLITUS | 5.41e-04 | 47 | 48 | 3 | M19708 | |
| Pathway | REACTOME_FCGR_ACTIVATION | 5.75e-04 | 48 | 48 | 3 | MM17214 | |
| Pathway | WP_PANCREATIC_CANCER_SUBTYPES | 5.75e-04 | 48 | 48 | 3 | M48093 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 6.12e-04 | 11 | 48 | 2 | MM14498 | |
| Pathway | REACTOME_PRESYNAPTIC_DEPOLARIZATION_AND_CALCIUM_CHANNEL_OPENING | 6.12e-04 | 11 | 48 | 2 | M26913 | |
| Pathway | REACTOME_ANTIGEN_ACTIVATES_B_CELL_RECEPTOR_BCR_LEADING_TO_GENERATION_OF_SECOND_MESSENGERS | 7.70e-04 | 53 | 48 | 3 | MM15716 | |
| Pathway | REACTOME_INITIAL_TRIGGERING_OF_COMPLEMENT | 8.14e-04 | 54 | 48 | 3 | MM14655 | |
| Pathway | REACTOME_KERATINIZATION | 8.25e-04 | 217 | 48 | 5 | M27640 | |
| Pathway | REACTOME_ROLE_OF_PHOSPHOLIPIDS_IN_PHAGOCYTOSIS | 9.05e-04 | 56 | 48 | 3 | MM14815 | |
| Pathway | REACTOME_FCERI_MEDIATED_CA_2_MOBILIZATION | 1.00e-03 | 58 | 48 | 3 | MM14914 | |
| Pathway | REACTOME_FCERI_MEDIATED_MAPK_ACTIVATION | 1.11e-03 | 60 | 48 | 3 | MM14913 | |
| Pathway | REACTOME_BINDING_AND_UPTAKE_OF_LIGANDS_BY_SCAVENGER_RECEPTORS | 1.11e-03 | 60 | 48 | 3 | MM14872 | |
| Pathway | REACTOME_DEVELOPMENTAL_BIOLOGY | 1.45e-03 | 502 | 48 | 7 | MM14537 | |
| Pathway | REACTOME_KERATINIZATION | 1.79e-03 | 153 | 48 | 4 | MM15343 | |
| Pathway | WP_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY | 2.03e-03 | 74 | 48 | 3 | M39462 | |
| Pathway | KEGG_ARRHYTHMOGENIC_RIGHT_VENTRICULAR_CARDIOMYOPATHY_ARVC | 2.03e-03 | 74 | 48 | 3 | M16376 | |
| Pathway | REACTOME_COMPLEMENT_CASCADE | 2.91e-03 | 84 | 48 | 3 | MM14653 | |
| Pubmed | 9.63e-09 | 3 | 75 | 3 | 29357356 | ||
| Pubmed | 9.63e-09 | 3 | 75 | 3 | 7543104 | ||
| Pubmed | Molecular Basis of Regulating High Voltage-Activated Calcium Channels by S-Nitrosylation. | 9.63e-09 | 3 | 75 | 3 | 26507659 | |
| Pubmed | 3.85e-08 | 4 | 75 | 3 | 15728831 | ||
| Pubmed | G protein-gated inhibitory module of N-type (ca(v)2.2) ca2+ channels. | 3.85e-08 | 4 | 75 | 3 | 15953418 | |
| Pubmed | TRIM25 and DEAD-Box RNA Helicase DDX3X Cooperate to Regulate RIG-I-Mediated Antiviral Immunity. | 4.73e-08 | 91 | 75 | 6 | 34445801 | |
| Pubmed | 9.60e-08 | 5 | 75 | 3 | 23075894 | ||
| Pubmed | 9.60e-08 | 5 | 75 | 3 | 11296258 | ||
| Pubmed | 9.60e-08 | 5 | 75 | 3 | 16787652 | ||
| Pubmed | 9.60e-08 | 5 | 75 | 3 | 15451373 | ||
| Pubmed | 9.60e-08 | 5 | 75 | 3 | 20301457 | ||
| Pubmed | 1.19e-07 | 54 | 75 | 5 | 35474131 | ||
| Pubmed | 1.25e-07 | 107 | 75 | 6 | 32989256 | ||
| Pubmed | Frizzled6 deficiency disrupts the differentiation process of nail development. | 3.35e-07 | 7 | 75 | 3 | 23439395 | |
| Pubmed | 8.02e-07 | 9 | 75 | 3 | 16382099 | ||
| Pubmed | 1.04e-06 | 245 | 75 | 7 | 35652658 | ||
| Pubmed | Reactive-site-centric chemoproteomics identifies a distinct class of deubiquitinase enzymes. | 1.10e-06 | 84 | 75 | 5 | 29563501 | |
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | IGF2BP3 CDK13 CLK3 RBM10 DNAJB6 PKP2 GIGYF2 CCT7 NKAP SPTY2D1 | 1.97e-06 | 678 | 75 | 10 | 30209976 |
| Pubmed | SPATA2 Links CYLD to LUBAC, Activates CYLD, and Controls LUBAC Signaling. | 3.24e-06 | 558 | 75 | 9 | 27591049 | |
| Pubmed | 4.30e-06 | 15 | 75 | 3 | 20188150 | ||
| Pubmed | 4.30e-06 | 15 | 75 | 3 | 24453333 | ||
| Pubmed | 1.3 A X-ray structure of an antibody Fv fragment used for induced membrane-protein crystallization. | 4.30e-06 | 15 | 75 | 3 | 12657787 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 21628556 | ||
| Pubmed | A Selectivity Filter Gate Controls Voltage-Gated Calcium Channel Calcium-Dependent Inactivation. | 4.59e-06 | 2 | 75 | 2 | 30733149 | |
| Pubmed | L-type calcium channels contribute to the tottering mouse dystonic episodes. | 4.59e-06 | 2 | 75 | 2 | 9882694 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 11118885 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 11489919 | ||
| Pubmed | Stable respiratory activity requires both P/Q-type and N-type voltage-gated calcium channels. | 4.59e-06 | 2 | 75 | 2 | 23426690 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 10866680 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 10953016 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 6207530 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 10550543 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 10550545 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 38155373 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 35959657 | ||
| Pubmed | Cytokeratins mediate epithelial innate defense through their antimicrobial properties. | 4.59e-06 | 2 | 75 | 2 | 23006328 | |
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 15050706 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 9790766 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 27418245 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 23662636 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 23376566 | ||
| Pubmed | 4.59e-06 | 2 | 75 | 2 | 22590648 | ||
| Pubmed | Comprehensive analysis of keratin gene clusters in humans and rodents. | 5.29e-06 | 16 | 75 | 3 | 15085952 | |
| Pubmed | 7.22e-06 | 57 | 75 | 4 | 31862882 | ||
| Pubmed | A functional reference map of the RNF8 interactome in cancer. | 7.95e-06 | 218 | 75 | 6 | 35831895 | |
| Pubmed | 9.87e-06 | 641 | 75 | 9 | 36057605 | ||
| Pubmed | 1.08e-05 | 63 | 75 | 4 | 16831889 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 28427417 | ||
| Pubmed | Defects of filaggrin-like proteins in both lesional and nonlesional atopic skin. | 1.37e-05 | 3 | 75 | 2 | 23403047 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 38996073 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 17170733 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 29466725 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 15601842 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 17851587 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 29587848 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 26216687 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 14573483 | ||
| Pubmed | A role for keratins in supporting mitochondrial organization and function in skin keratinocytes. | 1.37e-05 | 3 | 75 | 2 | 32213122 | |
| Pubmed | Loss of keratin 6 (K6) proteins reveals a function for intermediate filaments during wound repair. | 1.37e-05 | 3 | 75 | 2 | 14568992 | |
| Pubmed | Distinct roles for Cav2.1-2.3 in activity-dependent synaptic dynamics. | 1.37e-05 | 3 | 75 | 2 | 24523520 | |
| Pubmed | Ankyrin-B regulates Cav2.1 and Cav2.2 channel expression and targeting. | 1.37e-05 | 3 | 75 | 2 | 24394417 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 29166599 | ||
| Pubmed | Identification of a cloned sequence activated during multi-stage carcinogenesis in mouse skin. | 1.37e-05 | 3 | 75 | 2 | 1713533 | |
| Pubmed | Molecular moieties masking Ca2+-dependent facilitation of voltage-gated Cav2.2 Ca2+ channels. | 1.37e-05 | 3 | 75 | 2 | 29208674 | |
| Pubmed | Loss of calcium channels in the cerebellum of the ataxic and epileptic stargazer mutant mouse. | 1.37e-05 | 3 | 75 | 2 | 19422811 | |
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 23338940 | ||
| Pubmed | 1.37e-05 | 3 | 75 | 2 | 29581247 | ||
| Pubmed | Early onset of somatic mutation in immunoglobulin VH genes during the primary immune response. | 1.44e-05 | 22 | 75 | 3 | 2499654 | |
| Pubmed | Proteomic analyses reveal distinct chromatin-associated and soluble transcription factor complexes. | 1.53e-05 | 857 | 75 | 10 | 25609649 | |
| Pubmed | 2.16e-05 | 75 | 75 | 4 | 31527668 | ||
| Pubmed | Synapse and Active Zone Assembly in the Absence of Presynaptic Ca2+ Channels and Ca2+ Entry. | 2.75e-05 | 4 | 75 | 2 | 32616470 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 26283199 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 19065143 | ||
| Pubmed | Cerebellar granule cell signaling is indispensable for normal motor performance. | 2.75e-05 | 4 | 75 | 2 | 37141091 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 22279216 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 31253182 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 8910533 | ||
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 9054461 | ||
| Pubmed | Functional importance of L- and P/Q-type voltage-gated calcium channels in human renal vasculature. | 2.75e-05 | 4 | 75 | 2 | 21788606 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 30389720 | ||
| Pubmed | Dependence of parvalbumin expression on Purkinje cell input in the deep cerebellar nuclei. | 2.75e-05 | 4 | 75 | 2 | 9514513 | |
| Pubmed | Regional expression of L-type calcium channel subunits during cardiac development. | 2.75e-05 | 4 | 75 | 2 | 15108317 | |
| Pubmed | 2.75e-05 | 4 | 75 | 2 | 22264670 | ||
| Pubmed | Mouse models in preclinical studies for pachyonychia congenita. | 2.75e-05 | 4 | 75 | 2 | 16250208 | |
| Pubmed | The MAP1B-LC1/UBE2L3 complex catalyzes degradation of cell surface CaV2.2 channels. | 2.75e-05 | 4 | 75 | 2 | 25483588 | |
| Pubmed | KRT6A KRT6B IGHV3-33 IGF2BP3 RBMXL3 KRT6C CDK13 KRT77 CCT7 HRNR NPM3 | 3.56e-05 | 1153 | 75 | 11 | 29845934 | |
| Pubmed | 4.57e-05 | 32 | 75 | 3 | 19320717 | ||
| Pubmed | Three epidermal and one simple epithelial type II keratin genes map to human chromosome 12. | 4.57e-05 | 5 | 75 | 2 | 1713141 | |
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 8825650 | ||
| Pubmed | Airway hillocks are injury-resistant reservoirs of unique plastic stem cells. | 4.57e-05 | 5 | 75 | 2 | 38693267 | |
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 16917092 | ||
| Pubmed | 4.57e-05 | 5 | 75 | 2 | 31898934 | ||
| Pubmed | Role for keratins 6 and 17 during wound closure in embryonic mouse skin. | 4.57e-05 | 5 | 75 | 2 | 12557214 | |
| Pubmed | CHD3 and CHD4 form distinct NuRD complexes with different yet overlapping functionality. | 4.85e-05 | 605 | 75 | 8 | 28977666 | |
| Pubmed | CACNA1C DES KRT6A KRT6B KHDRBS3 MYO1A KRT6C CDK13 KRT77 DNAJB6 NFXL1 TOP1MT | 5.73e-05 | 1442 | 75 | 12 | 35575683 | |
| Pubmed | Voltage-gated calcium channels in developing GnRH-1 neuronal system in the mouse. | 6.84e-05 | 6 | 75 | 2 | 16029198 | |
| Pubmed | p63(+)Krt5(+) distal airway stem cells are essential for lung regeneration. | 6.84e-05 | 6 | 75 | 2 | 25383540 | |
| Pubmed | Direct interaction of the Rab3 effector RIM with Ca2+ channels, SNAP-25, and synaptotagmin. | 6.84e-05 | 6 | 75 | 2 | 11438518 | |
| Pubmed | 6.84e-05 | 6 | 75 | 2 | 16790075 | ||
| Pubmed | An action potential initiation mechanism in distal axons for the control of dopamine release. | 6.84e-05 | 6 | 75 | 2 | 35324301 | |
| Interaction | KRT84 interactions | 7.95e-07 | 49 | 71 | 5 | int:KRT84 | |
| Interaction | KRT17 interactions | 2.88e-06 | 252 | 71 | 8 | int:KRT17 | |
| Interaction | RNF208 interactions | 6.70e-06 | 75 | 71 | 5 | int:RNF208 | |
| Interaction | KRT25 interactions | 6.82e-06 | 35 | 71 | 4 | int:KRT25 | |
| Interaction | SCN11A interactions | 1.85e-05 | 15 | 71 | 3 | int:SCN11A | |
| Interaction | DES interactions | 1.99e-05 | 158 | 71 | 6 | int:DES | |
| Interaction | PHTF1 interactions | 4.58e-05 | 20 | 71 | 3 | int:PHTF1 | |
| Interaction | SCN9A interactions | 5.32e-05 | 21 | 71 | 3 | int:SCN9A | |
| Interaction | KRT13 interactions | 5.57e-05 | 116 | 71 | 5 | int:KRT13 | |
| Interaction | KRT5 interactions | 6.10e-05 | 193 | 71 | 6 | int:KRT5 | |
| Interaction | CACNB2 interactions | 7.05e-05 | 23 | 71 | 3 | int:CACNB2 | |
| Interaction | KRT20 interactions | 7.20e-05 | 63 | 71 | 4 | int:KRT20 | |
| Interaction | CACNA1A interactions | 7.36e-05 | 123 | 71 | 5 | int:CACNA1A | |
| Interaction | KRT12 interactions | 8.04e-05 | 24 | 71 | 3 | int:KRT12 | |
| Interaction | CACNA1D interactions | 8.04e-05 | 24 | 71 | 3 | int:CACNA1D | |
| Interaction | CACNB4 interactions | 9.12e-05 | 25 | 71 | 3 | int:CACNB4 | |
| Interaction | KHDRBS2 interactions | 9.23e-05 | 129 | 71 | 5 | int:KHDRBS2 | |
| Interaction | KRT36 interactions | 1.35e-04 | 74 | 71 | 4 | int:KRT36 | |
| Interaction | SCN1A interactions | 1.43e-04 | 29 | 71 | 3 | int:SCN1A | |
| Interaction | KRT28 interactions | 1.59e-04 | 30 | 71 | 3 | int:KRT28 | |
| Interaction | KRT7 interactions | 1.83e-04 | 80 | 71 | 4 | int:KRT7 | |
| Interaction | CACNB3 interactions | 1.93e-04 | 32 | 71 | 3 | int:CACNB3 | |
| Interaction | CYLD interactions | KRT6A KRT6B RBM10 KRT77 DNAJB6 MUC19 GIGYF2 CCT7 COL6A5 HRNR FLG2 | 2.14e-04 | 868 | 71 | 11 | int:CYLD |
| Interaction | KIF23 interactions | DES IGHV3-33 IGF2BP3 RBMXL3 MYO1A RBM12B PKP2 HRNR TOP1MT FLG2 SPTY2D1 INO80B | 2.36e-04 | 1031 | 71 | 12 | int:KIF23 |
| Interaction | KRT6A interactions | 2.53e-04 | 160 | 71 | 5 | int:KRT6A | |
| Interaction | KRT26 interactions | 2.53e-04 | 35 | 71 | 3 | int:KRT26 | |
| Interaction | CACNA1B interactions | 2.99e-04 | 37 | 71 | 3 | int:CACNA1B | |
| Interaction | KRT33B interactions | 3.26e-04 | 93 | 71 | 4 | int:KRT33B | |
| Interaction | HEXIM1 interactions | KRT6A KRT6B IGHV3-33 IGF2BP3 KRT6C CDK13 CLK3 KRT77 CCT7 HRNR NPM3 | 3.30e-04 | 913 | 71 | 11 | int:HEXIM1 |
| Interaction | DCAF4 interactions | 3.66e-04 | 378 | 71 | 7 | int:DCAF4 | |
| Interaction | ZUP1 interactions | 3.72e-04 | 174 | 71 | 5 | int:ZUP1 | |
| Interaction | KRT15 interactions | 4.13e-04 | 178 | 71 | 5 | int:KRT15 | |
| Cytoband | 12q13.13 | 4.66e-06 | 67 | 75 | 4 | 12q13.13 | |
| Cytoband | 14q32.33 | 3.76e-05 | 228 | 75 | 5 | 14q32.33 | |
| Cytoband | 2p13.2 | 1.72e-04 | 12 | 75 | 2 | 2p13.2 | |
| Cytoband | 10p11.21 | 4.42e-04 | 19 | 75 | 2 | 10p11.21 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr12q13 | 6.59e-04 | 423 | 75 | 5 | chr12q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr2p13 | 1.60e-03 | 140 | 75 | 3 | chr2p13 | |
| GeneFamily | Keratins, type II | 1.94e-06 | 27 | 61 | 4 | 609 | |
| GeneFamily | Calcium voltage-gated channel subunits | 8.99e-05 | 26 | 61 | 3 | 253 | |
| GeneFamily | ADAMTS like | 2.33e-04 | 7 | 61 | 2 | 947 | |
| GeneFamily | EF-hand domain containing|S100 fused type protein family | 2.33e-04 | 7 | 61 | 2 | 1350 | |
| GeneFamily | Immunoglobulin heavy locus at 14q32.33 | 4.18e-04 | 187 | 61 | 5 | 349 | |
| GeneFamily | RNA binding motif containing | 5.79e-03 | 213 | 61 | 4 | 725 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Non-Papillary_Muscle_Invasive_Urothelial_Carcinoma-6|TCGA-Bladder / Sample_Type by Project: Shred V9 | 3.81e-07 | 171 | 73 | 6 | 0e78389f8f3d54570a6deb3dd307b865b46307e9 | |
| ToppCell | droplet-Tongue-TONGUE-1m-Epithelial-suprabasal|Tongue / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-07 | 194 | 73 | 6 | a3adcdc8b87332e8beb9bcd70cf36424af10633d | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma-5|TCGA-Lung / Sample_Type by Project: Shred V9 | 1.08e-05 | 177 | 73 | 5 | a0c7d08469c513cecf87777c19876884f1511570 | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma-6|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.40e-05 | 187 | 73 | 5 | 2ca7928baf0c5e61f7294ed05e6e6f0e0adf9d3f | |
| ToppCell | TCGA-Skin-Primary_Tumor|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.52e-05 | 190 | 73 | 5 | e2b26a03c6ab24d9b0f4150c47597be37767d86e | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.52e-05 | 190 | 73 | 5 | 01fb45add4661bc86cd0a34fac35177907152dbb | |
| ToppCell | TCGA-Skin-Primary_Tumor-Melanoma-Skin_Cutaneous_Melanoma|TCGA-Skin / Sample_Type by Project: Shred V9 | 1.52e-05 | 190 | 73 | 5 | 3188c7bd225cbcf46a21e2fb784336cdd9665995 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.56e-05 | 191 | 73 | 5 | 8597a8af294f24496c317d995f07eb5dcc25c13c | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic-neutrophil|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.72e-05 | 195 | 73 | 5 | d3755929ebbbf5e3afde44281e9056ddb614a291 | |
| ToppCell | Smart-seq2-spleen_(Smart-seq2)-myeloid-myeloid_granulocytic|spleen_(Smart-seq2) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.72e-05 | 195 | 73 | 5 | 19853c654ac64b3ae3bc99841c6cb29c8aaba85c | |
| ToppCell | Smart-seq2-tissue-resident_(Smart-seq2)|Smart-seq2 / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 1.89e-05 | 199 | 73 | 5 | 8be7cb9d8b4f9707efb69c681c40e683fcd810e5 | |
| ToppCell | COVID-19-kidney-Technical/muscle_(EC)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.84e-05 | 128 | 73 | 4 | 91072ca56bce2c552a95edd67e17f43d8cc1de95 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1-Fibcd1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 6.21e-05 | 130 | 73 | 4 | c70fb77324916d220d842a575558a8245c276599 | |
| ToppCell | Hippocampus-Neuronal-Excitatory-eN1(Slc17a7)-eN1_1|Hippocampus / BrainAtlas - Mouse McCarroll V32 | 9.23e-05 | 144 | 73 | 4 | e2a2f260f5ebaaef46248d199c407a15ce9d024a | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.03e-04 | 148 | 73 | 4 | d6ac5972267254651dfbe16bb4e9a62228093cc7 | |
| ToppCell | TCGA-Bone_and_Soft_Tissue-Primary_Tumor-Sarcoma-Conventional_Leiomyosarcoma|TCGA-Bone_and_Soft_Tissue / Sample_Type by Project: Shred V9 | 1.17e-04 | 153 | 73 | 4 | ec6fe6b8c884fa76adc7a0f9db041f7b1567a2ee | |
| ToppCell | facs-Liver-Non-hepatocytes-3m-Endothelial-nan|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.23e-04 | 155 | 73 | 4 | 8fdda4e3657ac56188ae88ed3caf145f4d9d1567 | |
| ToppCell | TCGA-Bladder-Primary_Tumor-Urothelial_Carcinoma-Papillary_Muscle_Invasive_Urothelial_Carcinoma|TCGA-Bladder / Sample_Type by Project: Shred V9 | 1.32e-04 | 158 | 73 | 4 | dc559503bab3ec1b9ea54ef2e896d1be33e5344c | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Mes)|kidney / Disease (COVID-19 only), tissue and cell type | 1.35e-04 | 159 | 73 | 4 | 5335cbcdeaf2bbd0268bbfe0e45c8c0d288e640d | |
| ToppCell | COVID-19-kidney-Technical/muscle_(Imm)|kidney / Disease (COVID-19 only), tissue and cell type | 1.49e-04 | 163 | 73 | 4 | 19c28ce16a588a7f4a035c32726f6ccd67702b5b | |
| ToppCell | facs-Pancreas-Exocrine-18m-Epithelial-pancreatic_B_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.49e-04 | 163 | 73 | 4 | 132aece9c79499b4bb3c2bde68d3d7202e1d8772 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_intercalated_cell|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 1.52e-04 | 164 | 73 | 4 | d847d509bb1791638032ade6755d8164586b5bd5 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Degenerative_Fibroblast-Degenerative_Fibroblast_104|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.60e-04 | 166 | 73 | 4 | c11dcf9705b85ac3da6ae86358f5ffd64ae8327e | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Epithelial-Proximal_tubule_epithelial_cell-kidney_proximal_tubule_epithelial_cell-Degenerative_Proximal_Tubule_Epithelial_Cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 1.63e-04 | 167 | 73 | 4 | 3edb0570e583bb527165bcd8a4c25a042054043b | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte-type_1_alveolar_epithelial_cell|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-04 | 167 | 73 | 4 | 9f2661729a2d58e17a9203a563d538c08a3dbbbc | |
| ToppCell | facs-Lung-3m-Epithelial-alveolar_epithelial-type_I_pneumocyte|3m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.63e-04 | 167 | 73 | 4 | bebc2493a2ee41920b21c2b774a1c5a9619315c4 | |
| ToppCell | droplet-Heart-HEART_(ALL_MINUS_AORTA)-30m-Hematologic-fibroblast|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.63e-04 | 167 | 73 | 4 | f5bffa77061baec0ba87bd688a047595f32534db | |
| ToppCell | BAL-Mild-Lymphocyte-B|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.71e-04 | 169 | 73 | 4 | 307571e57c3bfdf15f0fe1a8b36585e8e4f8a207 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell-B_activate-7|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-04 | 170 | 73 | 4 | ee2ee67d90ae4596de8ccd620e37c82cf51651d4 | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-04 | 170 | 73 | 4 | d7ca0c6ce5d2b7de99346f87e07aa7fe728fa08a | |
| ToppCell | BAL-Mild-Lymphocyte-B-B_cell|Mild / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.75e-04 | 170 | 73 | 4 | 52787f6d529c285d9f0c04cc022710ead5b89b3f | |
| ToppCell | TCGA-Head_and_Esophagus|World / Sample_Type by Project: Shred V9 | 1.83e-04 | 172 | 73 | 4 | eb18aa179db1818f408c38e442ecfed8582d7dbc | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal-Basal_mature|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-04 | 174 | 73 | 4 | 97d4a40b536a67fa52f055eab26106d041bf3220 | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-04 | 174 | 73 | 4 | f9f399244c7d12caf8118ec3117d477a39e35c3b | |
| ToppCell | PND10-Epithelial-Epithelial_Airway-Basal|PND10 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.91e-04 | 174 | 73 | 4 | e8440eea7c81864defa57c89e9b569ad8033e5c5 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 174 | 73 | 4 | 2eee7b5471672b439f95eba11494c2adf8cb7006 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Epithelial_transtional-secretory-nasal_mucosa_goblet_cell-Goblet_(nasal)-Goblet_(nasal)_L.0.2.2.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.91e-04 | 174 | 73 | 4 | 207aa0118633cbe9a65839bbb1bb3ba9f8118ad2 | |
| ToppCell | facs-Heart-LV-24m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.91e-04 | 174 | 73 | 4 | 197686570cec6d96a92e77e6409325d3bfe6f991 | |
| ToppCell | Somatosensory_Cortex_(S1)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_2|Somatosensory_Cortex_(S1) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 1.91e-04 | 174 | 73 | 4 | b3cd22e717d178269e6d5bd5ed7b2d945cd8ea25 | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-04 | 175 | 73 | 4 | 96219e58dcb327fd27190be78193e7a0d611e62b | |
| ToppCell | PND14-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-AT1/AT2-AT1/AT2_mature|PND14 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.95e-04 | 175 | 73 | 4 | cb974fbebe8cb58c7d3f7defabb4e056f2fee5fa | |
| ToppCell | wk_15-18-Epithelial-Proximal_epithelial-Proximal_secretory_3|wk_15-18 / Celltypes from embryonic and fetal-stage human lung | 2.00e-04 | 176 | 73 | 4 | 8d9d0fb46c418b2067be58aec822e8c2b1561461 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.04e-04 | 177 | 73 | 4 | dbdbdc8ed9ef0b529694242ef9f9f07a42e16005 | |
| ToppCell | droplet-Heart-nan-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.08e-04 | 178 | 73 | 4 | 416f85e51f45ec7949451fd47611a84e33e87245 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 180 | 73 | 4 | dfb8412e1e06fa7349e66eea2ef27d9ea98b7893 | |
| ToppCell | Control-Fibroblasts-Airway_smooth_muscle|Control / group, cell type (main and fine annotations) | 2.17e-04 | 180 | 73 | 4 | d0de12749ef0f51f0931c6e7b9b99966bdbc3ec1 | |
| ToppCell | facs-Lung-EPCAM-24m-Myeloid-Dendritic_Cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 180 | 73 | 4 | 5b7d2336ed09d07f6b8dd91c1fa9c5ade633c104 | |
| ToppCell | facs-Heart-RV-3m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.17e-04 | 180 | 73 | 4 | 0059e5acade6c895fd629767bea1c15f40b0d1b0 | |
| ToppCell | Mid-temporal_gyrus_(MTG)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)-Glut_D_(IT_RORB_THEMIS_LINC00507)_5-Exc_L4-5_RORB_HNRNPA1P46|Mid-temporal_gyrus_(MTG) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 2.17e-04 | 180 | 73 | 4 | 8923a42a6db9c6e9f3ce2ca9530e620dfea700ba | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.27e-04 | 182 | 73 | 4 | 007fa56ed8b91f9af0df2114c00410b2f6cec8b6 | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|RA / Chamber and Cluster_Paper | 2.32e-04 | 183 | 73 | 4 | 818fd886e0188091310825f9145fa53328f2c979 | |
| ToppCell | droplet-Kidney-nan-21m-Mesenchymal-podocyte|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 183 | 73 | 4 | ad7421623e4c0c5ba02eec56e9bdae43ebb88d90 | |
| ToppCell | COVID-19-Heart-CM_4|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.32e-04 | 183 | 73 | 4 | 2902b6e8aa9a6f62bc1a792c971ab7f651a8e676 | |
| ToppCell | COVID-19-Epithelial_cells-ECM-high_epithelial|COVID-19 / group, cell type (main and fine annotations) | 2.32e-04 | 183 | 73 | 4 | dc1d380bf7564f290256cb7108063d1bd2da732b | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 183 | 73 | 4 | 99ab7a43527eb226027efbcd8c0b6a8e46fc3c93 | |
| ToppCell | Mild_COVID-19-B_cell|Mild_COVID-19 / Disease group,lineage and cell class (2021.01.30) | 2.32e-04 | 183 | 73 | 4 | dea119e2988e954475f557f0bbe12556a83e81a4 | |
| ToppCell | droplet-Liver-Npc-21m-Lymphocytic-B_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.32e-04 | 183 | 73 | 4 | 28916f0597690ff534578be2cb715b485cb1de1a | |
| ToppCell | RA-13._Vascular_Smooth_Muscle|World / Chamber and Cluster_Paper | 2.32e-04 | 183 | 73 | 4 | cae2ee08f985a6f005b4b8e959e465350315156a | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|LV / Chamber and Cluster_Paper | 2.36e-04 | 184 | 73 | 4 | ab7a1620c14a9d9b6be1b47c559931e345e9eef8 | |
| ToppCell | COVID-19-Heart-CM_2|COVID-19 / Disease (COVID-19 only), tissue and cell type | 2.41e-04 | 185 | 73 | 4 | 549eeb521c3985bff396ea0f202db21822efa51f | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1-D175|Adult / Lineage, Cell type, age group and donor | 2.41e-04 | 185 | 73 | 4 | 32b4e68e551d435a732f253f6ad83408c759a642 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.41e-04 | 185 | 73 | 4 | 30df02fbe2828e3c4f3e5c4cda855e74fb31be39 | |
| ToppCell | LV-15._Ventricular_Cardiomyocyte_III|World / Chamber and Cluster_Paper | 2.41e-04 | 185 | 73 | 4 | 6baccb26f999145e51b91d94315bf8d4655bef31 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.46e-04 | 186 | 73 | 4 | 6add08d4ca019ff2864acdd5ec2c66a59a574591 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 187 | 73 | 4 | 5fada3c5a58c1890029ccbfff2608b33f8cd2df7 | |
| ToppCell | droplet-Heart-4Chambers-21m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 187 | 73 | 4 | 8ff9f771d10c372d771c92dfa9006aa81aec4681 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-nan|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 187 | 73 | 4 | 766e808138fc2cd623c2e6d57fcb5c7378da0e03 | |
| ToppCell | droplet-Fat-SCAT-30m-Epithelial-epithelial_cell|Fat / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.51e-04 | 187 | 73 | 4 | f49d06600060deeb2fc1b1da5b93496535f20104 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.57e-04 | 188 | 73 | 4 | 293f2fa99f5f96aa7fd2b2a5cc94ff60eeaabe11 | |
| ToppCell | LV-14._Fibroblast_III|World / Chamber and Cluster_Paper | 2.62e-04 | 189 | 73 | 4 | 3922135d1f6fc768d71ba3b465585fead6ea68a8 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-Stroma____kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.62e-04 | 189 | 73 | 4 | a959c9d6a0866582688a4204d625c1e5a123e93d | |
| ToppCell | RV-04._Ventricular_Cardiomyocyte_I|RV / Chamber and Cluster_Paper | 2.62e-04 | 189 | 73 | 4 | 9c1debd65c13d63fd4f3158917d621b44b714c26 | |
| ToppCell | TCGA-Cervix-Primary_Tumor-Cervical_Carcinoma|TCGA-Cervix / Sample_Type by Project: Shred V9 | 2.62e-04 | 189 | 73 | 4 | 533c302df467d13ab639232daf4f8cafb808260b | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Lung_smooth_muscle|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-04 | 189 | 73 | 4 | 7ab1cfc1657277858339f7258a0c4ae9cb42fdf8 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.62e-04 | 189 | 73 | 4 | 45e588b2a4ad9e3ff74e22d9d627ed3571f3b8b8 | |
| ToppCell | TCGA-Lung-Primary_Tumor-Lung_Carcinoma-Lung_Squamous_Cell_Carcinoma|TCGA-Lung / Sample_Type by Project: Shred V9 | 2.62e-04 | 189 | 73 | 4 | aa4f7d7a5196e5ae481ebc2549de8e3f0ef6e6be | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-Lgr5-_amplifying_undifferentiated_cell|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-04 | 190 | 73 | 4 | 36e83995021ba16690f84e2077a9e8baec547d05 | |
| ToppCell | droplet-Large_Intestine-COLON_PROXIMAL-30m-Epithelial-epithelial_cell_of_large_intestine|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.67e-04 | 190 | 73 | 4 | d26be9e1b676f750e716b91ebc3598fac3735612 | |
| ToppCell | Control-Stromal_mesenchymal|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.72e-04 | 191 | 73 | 4 | 14057205ddb9b4bbc582d1358d13cf36d979a61b | |
| ToppCell | LA-03._Atrial_Cardiomyocyte|LA / Chamber and Cluster_Paper | 2.72e-04 | 191 | 73 | 4 | 5d1b674eb7703830b7ce8bbeac3363cabd0e6ae9 | |
| ToppCell | Control-Stromal_mesenchymal-Lung_smooth_muscle-Myofibroblast|Control / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.72e-04 | 191 | 73 | 4 | b133ee1c0e58d00ddd2e4e05b01fd04947524c18 | |
| ToppCell | droplet-Kidney-nan-3m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.78e-04 | 192 | 73 | 4 | 3617d2bc7e33d981f3ec349e9962d8d4bd822fbd | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-04 | 193 | 73 | 4 | 1043b28503bfaa0d5a82ec358bc86cbde73ea8f2 | |
| ToppCell | droplet-Heart-HEART_(LV+RV_ONLY)-30m-Mesenchymal-smooth_muscle_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.83e-04 | 193 | 73 | 4 | 0266a4fdf436d83ec1d9392abba8c6ec5166970a | |
| ToppCell | COVID-19-Heart-CM_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 2.83e-04 | 193 | 73 | 4 | dd5378a1ef8eb0eda9a3aae62f3c2f3a1402bda0 | |
| ToppCell | droplet-Kidney-KIDNEY-1m-Epithelial-kidney_mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.89e-04 | 194 | 73 | 4 | 80be44e9ddd9f6ddd9dff7cba0eb457431204c2d | |
| ToppCell | RA-03._Atrial_Cardiomyocyte|RA / Chamber and Cluster_Paper | 2.89e-04 | 194 | 73 | 4 | c3535f7cc0076653c72db582047cff053c322397 | |
| ToppCell | (10)_Ciliated-(0)_Reference|(10)_Ciliated / shred by cell type by condition | 2.89e-04 | 194 | 73 | 4 | f9d5bf6baddbd88947e6a740805962109649ed3b | |
| ToppCell | COVID-19-Heart-CM_2|Heart / Disease (COVID-19 only), tissue and cell type | 2.95e-04 | 195 | 73 | 4 | 75fc81bddb246dca3b437fb60827b1d4fe416405 | |
| ToppCell | Bronchial-NucSeq-Epithelial-Epi_airway_basal-Basal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-04 | 197 | 73 | 4 | 1e915957ea6a4550ecb9d6ee4b232aa5800faf20 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.06e-04 | 197 | 73 | 4 | 2430f31d9312338e0ca23bfc6bdb0365340860fd | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_pulmonary|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.06e-04 | 197 | 73 | 4 | ac4f53acb2f8a428b0f2fab3c30a34e095a1bed7 | |
| ToppCell | 10x_3'_v3-tissue-resident_(10x_3'_v3)-myeloid-myeloid_monocytic-leukocyte|tissue-resident_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 3.06e-04 | 197 | 73 | 4 | d968d7d5608b175bb567ea3a315bf473ec3be459 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.2.4|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.12e-04 | 198 | 73 | 4 | 77517df37dc894c78ef1e2b24dd7ba31f928bdb7 | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Basal_resting-Basal_resting_L.0.0.0.2|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 3.12e-04 | 198 | 73 | 4 | fc00cb25cdc6c31b7f9d397bc9f9a8f4e9708003 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.18e-04 | 199 | 73 | 4 | b768496381362f9a2706e0892b5a7a0db82e09ce | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Proliferative_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.18e-04 | 199 | 73 | 4 | eb5971660dff356721a004f821d52a5b7a33c951 | |
| ToppCell | distal-1-Epithelial-Proliferating_Basal|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 3.18e-04 | 199 | 73 | 4 | 93450257180d918c310bca7b5defc74390c48091 | |
| ToppCell | LPS_only-Mesenchymal_fibroblastic-Fibroblasts-Diff_MatrixFB|LPS_only / Treatment groups by lineage, cell group, cell type | 3.24e-04 | 200 | 73 | 4 | ab4fda0cc95cb8f80ea9f28745013f3248def820 | |
| ToppCell | Neuronal-Excitatory-eG(DAPK2)-|Neuronal / cells hierarchy compared to all cells using T-Statistic | 3.24e-04 | 200 | 73 | 4 | 7cea58e2691564e653cc972bf5aaff2df1f2666e | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.58e-04 | 50 | 35 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPI3 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 5.58e-04 | 50 | 35 | 3 | GAVISH_3CA_METAPROGRAM_EPITHELIAL_EPISEN | |
| Drug | SC-791 | 5.06e-07 | 6 | 68 | 3 | CID010291510 | |
| Drug | Doxycycline hydrochloride [10592-13-9]; Down 200; 8.4uM; HL60; HT_HG-U133A | 1.96e-06 | 196 | 68 | 7 | 2737_DN | |
| Drug | AC1L1JG6 | 9.06e-06 | 14 | 68 | 3 | CID000005026 | |
| Drug | butamben | 1.13e-05 | 15 | 68 | 3 | CID000002482 | |
| Drug | Verapamil | 1.39e-05 | 16 | 68 | 3 | DB00661 | |
| Drug | mant-GTP | 1.51e-05 | 50 | 68 | 4 | CID000128647 | |
| Drug | clobestasol propionate | 1.68e-05 | 17 | 68 | 3 | CID000002791 | |
| Drug | CD-III | 1.91e-05 | 53 | 68 | 4 | CID000066693 | |
| Drug | dithranol | 2.01e-05 | 18 | 68 | 3 | CID000002202 | |
| Drug | cignolin | 2.38e-05 | 56 | 68 | 4 | CID000010187 | |
| Drug | Harmine hydrochloride [343-27-1]; Up 200; 16uM; PC3; HT_HG-U133A | 2.50e-05 | 194 | 68 | 6 | 5855_UP | |
| Drug | Pyrithyldione [77-04-3]; Up 200; 24uM; MCF7; HT_HG-U133A | 2.72e-05 | 197 | 68 | 6 | 6801_UP | |
| Drug | Olux | 2.80e-05 | 20 | 68 | 3 | CID000032797 | |
| Drug | N1-acetylspermidine | 2.80e-05 | 20 | 68 | 3 | CID000000496 | |
| Drug | Phensuximide [86-34-0]; Up 200; 21.2uM; MCF7; HT_HG-U133A | 2.80e-05 | 198 | 68 | 6 | 5522_UP | |
| Drug | NSC759256 | 3.80e-05 | 63 | 68 | 4 | CID000125889 | |
| Drug | MK-6 | 4.93e-05 | 24 | 68 | 3 | CID005283547 | |
| Drug | AC 110 | 5.25e-05 | 4 | 68 | 2 | CID000022860 | |
| Drug | Bhg-(2-1)fuc | 5.59e-05 | 25 | 68 | 3 | CID005287784 | |
| Drug | ethosuximide | 7.15e-05 | 74 | 68 | 4 | CID000003291 | |
| Drug | betamethasone valerate | 7.91e-05 | 28 | 68 | 3 | CID000016533 | |
| Drug | S 8510 | 8.74e-05 | 5 | 68 | 2 | CID005488383 | |
| Drug | N-cyclopentyl-N-cyclobutylformamide | 9.24e-05 | 79 | 68 | 4 | CID005287890 | |
| Drug | plakin | 1.07e-04 | 82 | 68 | 4 | CID000018752 | |
| Drug | 2-Formyl-Protoporphryn Ix | 1.08e-04 | 31 | 68 | 3 | CID011963946 | |
| Drug | AGN 193109 | 1.08e-04 | 31 | 68 | 3 | CID000177238 | |
| Drug | 4,4'-thiodiphenol | 1.19e-04 | 32 | 68 | 3 | CID000017570 | |
| Drug | CNS 1145 | 1.30e-04 | 33 | 68 | 3 | CID000190902 | |
| Drug | IHC-64 | 1.30e-04 | 33 | 68 | 3 | CID000162753 | |
| Drug | 3,4-dihydroquinazoline | 1.31e-04 | 6 | 68 | 2 | CID000583065 | |
| Drug | alpha-sialylcholesterol | 1.31e-04 | 6 | 68 | 2 | CID000133976 | |
| Drug | al-Badry | 1.36e-04 | 165 | 68 | 5 | CID000004545 | |
| Drug | Amlodipine | 1.83e-04 | 7 | 68 | 2 | DB00381 | |
| Drug | APMPA | 1.83e-04 | 7 | 68 | 2 | CID000512300 | |
| Drug | chrysarobin | 1.84e-04 | 37 | 68 | 3 | CID000068111 | |
| Drug | tsuwabukinonol | 1.84e-04 | 37 | 68 | 3 | CID006440419 | |
| Drug | 1-EBIO | 1.84e-04 | 37 | 68 | 3 | CID000082320 | |
| Drug | manidipine | 1.89e-04 | 95 | 68 | 4 | CID000004008 | |
| Drug | CaLam | 2.16e-04 | 39 | 68 | 3 | CID004126474 | |
| Drug | 0297417-0002B [362658-29-5]; Up 200; 10uM; MCF7; HT_HG-U133A | 2.43e-04 | 187 | 68 | 5 | 6902_UP | |
| Drug | Pregnenolone [145-13-1]; Down 200; 12.6uM; HL60; HT_HG-U133A | 2.55e-04 | 189 | 68 | 5 | 2497_DN | |
| Drug | AC1L9MJT | 2.74e-04 | 192 | 68 | 5 | CID000448959 | |
| Drug | Proguanil hydrochloride [637-32-1]; Down 200; 13.8uM; MCF7; HT_HG-U133A | 2.74e-04 | 192 | 68 | 5 | 3505_DN | |
| Drug | loperamide | 2.77e-04 | 105 | 68 | 4 | CID000003954 | |
| Drug | Isoetharine mesylate salt [7279-75-6]; Down 200; 12uM; HL60; HT_HG-U133A | 2.88e-04 | 194 | 68 | 5 | 2711_DN | |
| Drug | Glycocholic acid [475-31-0]; Down 200; 8.6uM; HL60; HT_HG-U133A | 2.95e-04 | 195 | 68 | 5 | 2454_DN | |
| Drug | Gentamicine sulfate [1405-41-0]; Down 200; 2.6uM; MCF7; HT_HG-U133A | 2.95e-04 | 195 | 68 | 5 | 2245_DN | |
| Drug | Liothyronine [6893-02-3]; Down 200; 6.2uM; MCF7; HT_HG-U133A | 2.95e-04 | 195 | 68 | 5 | 4947_DN | |
| Drug | (S)-propranolol hydrochloride [4199-10-4]; Up 200; 13.6uM; HL60; HT_HG-U133A | 3.02e-04 | 196 | 68 | 5 | 2961_UP | |
| Drug | Diphemanil methylsulfate [62-97-5]; Down 200; 10.2uM; PC3; HT_HG-U133A | 3.02e-04 | 196 | 68 | 5 | 4591_DN | |
| Drug | Clindamycin hydrochloride [21462-39-5]; Down 200; 8.6uM; MCF7; HT_HG-U133A | 3.02e-04 | 196 | 68 | 5 | 2219_DN | |
| Drug | Tenoxicam [59804-37-4]; Down 200; 11.8uM; MCF7; HT_HG-U133A | 3.02e-04 | 196 | 68 | 5 | 4182_DN | |
| Drug | Ciprofloxacin hydrochloride [93107-08-5]; Down 200; 10.8uM; PC3; HG-U133A | 3.02e-04 | 196 | 68 | 5 | 1939_DN | |
| Drug | Sulfanilamide [63-74-1]; Down 200; 23.2uM; HL60; HT_HG-U133A | 3.09e-04 | 197 | 68 | 5 | 2709_DN | |
| Drug | Levodopa [59-92-7]; Up 200; 20.2uM; MCF7; HT_HG-U133A | 3.09e-04 | 197 | 68 | 5 | 4394_UP | |
| Drug | Phentolamine hydrochloride [73-05-2]; Down 200; 12.6uM; PC3; HT_HG-U133A | 3.09e-04 | 197 | 68 | 5 | 4336_DN | |
| Drug | Edrophonium chloride [116-38-1]; Up 200; 19.8uM; MCF7; HT_HG-U133A | 3.09e-04 | 197 | 68 | 5 | 5001_UP | |
| Drug | Roxarsone [121-19-7]; Up 200; 15.2uM; MCF7; HT_HG-U133A | 3.16e-04 | 198 | 68 | 5 | 5470_UP | |
| Drug | Ethoxyquin [91-53-2]; Down 200; 18.4uM; PC3; HT_HG-U133A | 3.16e-04 | 198 | 68 | 5 | 3764_DN | |
| Drug | Galanthamine hydrobromide [1953-04-4]; Up 200; 10.8uM; MCF7; HT_HG-U133A | 3.24e-04 | 199 | 68 | 5 | 2787_UP | |
| Drug | Rifampicin [13292-46-1]; Down 200; 4.8uM; PC3; HT_HG-U133A | 3.24e-04 | 199 | 68 | 5 | 4008_DN | |
| Drug | Levocabastine hydrochloride [79547-78-7]; Down 200; 8.8uM; MCF7; HT_HG-U133A | 3.24e-04 | 199 | 68 | 5 | 7009_DN | |
| Drug | Sulfamethoxypyridazine [80-35-3]; Down 200; 14.2uM; HL60; HT_HG-U133A | 3.24e-04 | 199 | 68 | 5 | 2550_DN | |
| Drug | Homosalate [118-56-9]; Down 200; 15.2uM; MCF7; HT_HG-U133A | 3.24e-04 | 199 | 68 | 5 | 3879_DN | |
| Drug | Nalbuphine hydrochloride [23277-43-2]; Up 200; 10.2uM; PC3; HT_HG-U133A | 3.24e-04 | 199 | 68 | 5 | 5820_UP | |
| Drug | felodipine; Down 200; 10uM; MCF7; HG-U133A | 3.24e-04 | 199 | 68 | 5 | 337_DN | |
| Drug | Biperiden hydrochloride [1235-82-1]; Up 200; 11.4uM; MCF7; HT_HG-U133A | 3.24e-04 | 199 | 68 | 5 | 5279_UP | |
| Drug | h PM | 3.31e-04 | 45 | 68 | 3 | CID005494424 | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A | 3.31e-04 | 200 | 68 | 5 | 2077_UP | |
| Drug | Pimethixene maleate [13187-06-9]; Up 200; 9.8uM; HL60; HT_HG-U133A | 3.31e-04 | 200 | 68 | 5 | 2395_UP | |
| Drug | estradiol, USP; Down 200; 0.01uM; MCF7; HT_HG-U133A | 3.31e-04 | 200 | 68 | 5 | 1666_DN | |
| Disease | MUSCULAR DYSTROPHY, LIMB-GIRDLE, TYPE 1E | 4.93e-06 | 2 | 66 | 2 | C3148763 | |
| Disease | familial hemiplegic migraine 1 (implicated_via_orthology) | 1.48e-05 | 3 | 66 | 2 | DOID:0111181 (implicated_via_orthology) | |
| Disease | Pachyonychia Congenita, Jadassohn Lewandowsky Type | 2.95e-05 | 4 | 66 | 2 | C1706595 | |
| Disease | pachyonychia congenita (is_implicated_in) | 2.95e-05 | 4 | 66 | 2 | DOID:0050449 (is_implicated_in) | |
| Disease | migraine (implicated_via_orthology) | 2.95e-05 | 4 | 66 | 2 | DOID:6364 (implicated_via_orthology) | |
| Disease | Pachyonychia congenita syndrome | 2.95e-05 | 4 | 66 | 2 | cv:C0265334 | |
| Disease | Pachyonychia Congenita, Type 2 (disorder) | 2.95e-05 | 4 | 66 | 2 | C1721007 | |
| Disease | Pachyonychia Congenita | 4.91e-05 | 5 | 66 | 2 | C0265334 | |
| Disease | able to hear with hearing aids | 1.03e-04 | 7 | 66 | 2 | EFO_0009720 | |
| Disease | hereditary ataxia (implicated_via_orthology) | 1.03e-04 | 7 | 66 | 2 | DOID:0050951 (implicated_via_orthology) | |
| Disease | Muscular dystrophy, limb-girdle, autosomal dominant | 2.19e-04 | 10 | 66 | 2 | cv:C5675009 | |
| Disease | arrhythmogenic right ventricular cardiomyopathy (is_implicated_in) | 2.19e-04 | 10 | 66 | 2 | DOID:0050431 (is_implicated_in) | |
| Disease | hearing loss | 4.62e-04 | 67 | 66 | 3 | EFO_0004238 | |
| Disease | response to radiation | 1.02e-03 | 88 | 66 | 3 | GO_0009314 | |
| Disease | Brugada Syndrome (disorder) | 1.32e-03 | 24 | 66 | 2 | C1142166 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol consumption measurement | 1.44e-03 | 99 | 66 | 3 | EFO_0004611, EFO_0007878 | |
| Disease | Limb-girdle muscular dystrophy | 1.55e-03 | 26 | 66 | 2 | cv:C0686353 | |
| Disease | low density lipoprotein cholesterol measurement, alcohol drinking | 1.57e-03 | 102 | 66 | 3 | EFO_0004329, EFO_0004611 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| SRASGVTGRRETPGP | 386 | A9YTQ3 | |
| QGGSRESRSGSPRTG | 936 | O00555 | |
| PGTSLLGRGARRSGE | 71 | P49761 | |
| PCRSLGSRGRGSSGA | 36 | Q9HCU4 | |
| TSGASTPGRGGRRQL | 2176 | Q00975 | |
| GHISTSTGRGRGRGL | 1496 | Q14004 | |
| ESEPSSRGGSLRRGG | 621 | O14641 | |
| VVPRGGSVSQRGSIG | 471 | O60312 | |
| KRTDRVGRGRPGSGT | 86 | Q8IXT5 | |
| VGRGRPGSGTSGVDS | 91 | Q8IXT5 | |
| QTRVRGSGLGARGSS | 891 | P98175 | |
| VNSTGRRGRGTLGRP | 86 | Q68EN5 | |
| SPTASLVTGGREGRG | 1321 | Q8N1W1 | |
| PRGGTDTAGERGGSR | 86 | Q96SQ7 | |
| REGTRRGTEGSSGPA | 476 | Q6NSJ2 | |
| TATSGGGGRTRREAP | 2881 | Q96JQ0 | |
| GLTTQTGSRTTGRRG | 1711 | Q5D862 | |
| IQTGSRTTGRRGSGH | 1941 | Q5D862 | |
| ISVSRSRGSGGLGGA | 36 | P48668 | |
| SGGGVVQPGRSLRLS | 26 | P0DP03 | |
| GLSGRPGGSETSARR | 26 | Q96AQ8 | |
| GRGRSRGRATAAPSG | 11 | Q6ZNB6 | |
| SRTRAGGVGGLRVPA | 16 | O75607 | |
| VSVSRSRGSGGLGGA | 36 | P02538 | |
| SGIPASGIRDGRGVR | 286 | Q9UBC5 | |
| SGGGVVQPGRSLRLS | 26 | P0DP02 | |
| SGGAGPLSGSARRGR | 26 | O00221 | |
| GGEGAGSPRRTSRVS | 271 | Q96KN9 | |
| RTSSTGDAGGGSRRP | 1146 | Q8N6G6 | |
| RPTRGGSQRSRGTAG | 506 | Q6ZUT6 | |
| RGGGRGGRRNTTPSV | 36 | Q969W3 | |
| RSTAGTPRSGCGLTR | 121 | O43424 | |
| SRSRSPLAREGAGGG | 81 | Q8N3Y1 | |
| RGPRAGGTRLTLNGS | 1171 | O43157 | |
| ISVSRSRGSGGLGGA | 36 | P04259 | |
| GIRATRTEAPGGTSG | 6541 | Q7Z5P9 | |
| GRQGSGSGHSPSRVR | 766 | Q86YZ3 | |
| ISRLTGREGTGQPGR | 711 | Q9P1Y6 | |
| PGVGTSGRGTLRALR | 11 | Q8IVB5 | |
| SGRGTLRALRPGVTG | 16 | Q8IVB5 | |
| SGGGVVRPGGSLRLS | 26 | A0A0C4DH32 | |
| PVGRSGGGASARSSR | 261 | Q96S07 | |
| RRGLGQRGSSRQGSP | 171 | O00425 | |
| RRGGSLGQTARSGPA | 316 | Q15722 | |
| RLTKTAATSGRGGRG | 241 | Q9C086 | |
| RRGPRGSRSRGTGSF | 126 | O75190 | |
| TTPGGGGSSAARRVR | 2081 | Q13936 | |
| GTVVGAPRGRSSSRG | 111 | Q6Y7W6 | |
| GSPSSRGSRGREGQR | 1546 | A8TX70 | |
| VSRTSGGAGGLGSLR | 56 | P17661 | |
| SGGGVVQPGRSLRLS | 26 | P01768 | |
| GGSGRGRRAERVSPS | 526 | Q8TF61 | |
| AITRGRGGVTARPVG | 201 | O75525 | |
| RGVLSTRGPVSRGRG | 226 | O75525 | |
| SLRARPGSGASRGQG | 126 | Q9H2J1 | |
| VSVAGSGTRRGSPAV | 41 | Q03060 | |
| GRTGRAGRTGVSITT | 576 | Q9NXZ2 | |
| GSRSPDREASGSGGR | 6 | Q8N5F7 | |
| SGGGVVQPGRSLRLS | 26 | P01772 | |
| VRLPGRAQSGTRGGA | 41 | P49247 | |
| IPIGGGSRGAGRVSR | 96 | Q9UK53 | |
| PSAVRAGGAVLSGRG | 61 | Q9NTG1 | |
| TVDAPTAAGRGRGRG | 526 | Q99832 | |
| GPSGGGSTRDQVRTV | 21 | Q8TE82 | |
| AGRAGRRGLDPTGTV | 701 | Q15477 | |
| REPGDVSARTRSGGG | 196 | B3KU38 | |
| GRSVSGPGRSISGSI | 486 | Q68D10 | |
| RPGRAVASVGSGTDR | 306 | Q6ZU45 | |
| GGPRRGFASITITAR | 131 | Q96M02 | |
| SRGSRRPGTRAGLGS | 6 | Q15735 | |
| SGSTSSPGRGRGEVR | 331 | Q15036 | |
| AGRGGPATARSRVSA | 66 | Q96NJ1 | |
| VPRDRGGRGAGSQST | 56 | Q6ZSN1 | |
| RAVPRSSLARIGGSG | 206 | Q8N7X1 | |
| ATGGGSGSLAARRPV | 451 | Q2M3V2 | |
| SDGGGGVSRTRGRPS | 21 | Q8N554 | |
| RGVPGSRRTQKGSGA | 26 | Q969P6 | |
| RSTAGPGTLGQGSLR | 496 | Q8TEC5 | |
| TGDRRSRTRGTIGPG | 151 | Q6ZMP0 | |
| IQGRGASGISGRRST | 1221 | Q6ZQQ6 | |
| PSTLGGQGGRITRSG | 481 | Q99959 | |
| GSGRSGRGSSRVQII | 551 | Q7Z794 | |
| SRTPAGRGAGTSARG | 676 | Q9ULH4 | |
| RSRGRPSTGGGVVRG | 341 | P28698 |